Clinical Trials Logo
NCT number NCT03297294
Study type Interventional
Source Novartis
Contact Novartis Pharmaceuticals
Phone +41613241111
Email novartis.email@novartis.com
Status Not yet recruiting
Phase Phase 2
Start date March 15, 2018
Completion date April 19, 2019

Clinical Trial Summary

The purpose of this study is to evaluate safety and efficacy of EMA401 compared to placebo in patients with painful diabetic neuropathy (PDN).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


See also
  Status Clinical Trial Phase
Unknown status NCT01125215 - Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy Phase 2/Phase 3
Terminated NCT01129960 - Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain Phase 3
Terminated NCT01056315 - A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y Phase 2
Completed NCT00980746 - Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Painful Diabetic Neuropathy Phase 2
Completed NCT00695565 - Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy Phase 2
Completed NCT00546351 - Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy. Phase 3
Recruiting NCT03202979 - Trazodone in Painful Diabetic Neuropathy Phase 2
Completed NCT02068027 - Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy Phase 2
Completed NCT00337324 - Electromagnetic Stimulation (FREMS) in Patients With Painful Diabetic Neuropathy Phase 2/Phase 3
Completed NCT02355158 - A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy Phase 2
Completed NCT00350103 - A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy Phase 3
Completed NCT00861445 - A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy Phase 2
Recruiting NCT03066570 - Graded Exposure in Patients With Painful Diabetic Neuropathy N/A
Completed NCT00781001 - Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy Phase 1/Phase 2
Recruiting NCT03228420 - Comparison of 10 kHz SCS Combined With CMM to CMM Alone in the Treatment of Neuropathic Limb Pain N/A
Completed NCT01521598 - A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy Phase 2
Completed NCT00703209 - Study on the Role of Decompression of Lower Extremity Nerves for the Treatment of Patients With Symptomatic Diabetic Neuropathy With Chronic Nerve Compression N/A
Completed NCT01002235 - Gene Therapy for Painful Diabetic Neuropathy Phase 1/Phase 2
Completed NCT02643251 - The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy Phase 2
Completed NCT00220337 - A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy Phase 3